Investigational Monoclonal Antibodies in the Treatment of Multiple Myeloma: A Systematic Review of Agents under Clinical Development

Investigational Monoclonal Antibodies in the Treatment of Multiple Myeloma: A Systematic Review of Agents under Clinical Development

Background: Immunotherapy for multiple myeloma (MM) has been the focus in recent years due to its myeloma-specific immune responses. We reviewed the literature on non-Food and Drug Administration (FDA) approved monoclonal antibodies (mAbs) to highlight future perspectives. We searched PubMed, EMBASE...

Full description

Bibliographic Details
Main Authors: Ahmad Iftikhar, Hamza Hassan, Nimra Iftikhar, Adeela Mushtaq, Atif Sohail, Nathaniel Rosko, Rajshekhar Chakraborty, Faryal Razzaq, Sonia Sandeep, Jason Neil Valent, Abraham Sebastian Kanate, Faiz Anwer
Format: Article
Language:English
Published: MDPI AG 2019-05-01
Series:Antibodies
Subjects:
Multiple myeloma
immunotherapy
antibody
targeted therapy
molecular targets
bispecific antibodies
immune checkpoint inhibitors
Antibody Drug Conjugate
Online Access:https://www.mdpi.com/2073-4468/8/2/34

Internet

https://www.mdpi.com/2073-4468/8/2/34

Similar Items